Page last updated: 2024-08-26

bosentan anhydrous and Cancer Pain

bosentan anhydrous has been researched along with Cancer Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acco, A; Chichorro, JG; Dos Reis, RC; Gambeta, E; King, T; Kopruszinski, CM; Rae, GA	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Cancer Pain

Article	Year
Blockade of endothelin receptors reduces tumor-induced ongoing pain and evoked hypersensitivity in a rat model of facial carcinoma induced pain. European journal of pharmacology, 2018, Jan-05, Volume: 818 Topics: Animals; Bosentan; Cancer Pain; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Endothelin Receptor Antagonists; Facial Neoplasms; Hyperalgesia; Male; Morphine; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides	2018

Article

Year

Blockade of endothelin receptors reduces tumor-induced ongoing pain and evoked hypersensitivity in a rat model of facial carcinoma induced pain.

European journal of pharmacology, 2018, Jan-05, Volume: 818

Topics: Animals; Bosentan; Cancer Pain; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Endothelin Receptor Antagonists; Facial Neoplasms; Hyperalgesia; Male; Morphine; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides

2018